217 related articles for article (PubMed ID: 30395440)
1. Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma.
Jiang Y; Zhang J; Meng F; Zhong Z
ACS Nano; 2018 Nov; 12(11):11070-11079. PubMed ID: 30395440
[TBL] [Abstract][Full Text] [Related]
2. Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice.
Qin H; Jiang Y; Zhang J; Deng C; Zhong Z
Mol Pharm; 2019 Aug; 16(8):3711-3719. PubMed ID: 31299161
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice.
Ouyang J; Jiang Y; Deng C; Zhong Z; Lan Q
Int J Nanomedicine; 2021; 16():4105-4115. PubMed ID: 34163162
[TBL] [Abstract][Full Text] [Related]
4. Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo.
Jiang Y; Yang W; Zhang J; Meng F; Zhong Z
Adv Mater; 2018 Jul; 30(30):e1800316. PubMed ID: 29893017
[TBL] [Abstract][Full Text] [Related]
5. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
[TBL] [Abstract][Full Text] [Related]
6. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
[TBL] [Abstract][Full Text] [Related]
7. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes.
Shi Y; Jiang Y; Cao J; Yang W; Zhang J; Meng F; Zhong Z
J Control Release; 2018 Dec; 292():163-171. PubMed ID: 30408555
[TBL] [Abstract][Full Text] [Related]
8. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
[TBL] [Abstract][Full Text] [Related]
9. A dual-targeting peptide for glioblastoma screened by phage display peptide library biopanning combined with affinity-adaptability analysis.
Li X; Pu X; Wang X; Wang J; Liao X; Huang Z; Yin G
Int J Pharm; 2023 Sep; 644():123306. PubMed ID: 37572856
[TBL] [Abstract][Full Text] [Related]
10. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
[TBL] [Abstract][Full Text] [Related]
11. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
12. Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier.
Monaco I; Camorani S; Colecchia D; Locatelli E; Calandro P; Oudin A; Niclou S; Arra C; Chiariello M; Cerchia L; Comes Franchini M
J Med Chem; 2017 May; 60(10):4510-4516. PubMed ID: 28471660
[TBL] [Abstract][Full Text] [Related]
13. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
[TBL] [Abstract][Full Text] [Related]
14. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
15. Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A.
Böckenhoff A; Cramer S; Wölte P; Knieling S; Wohlenberg C; Gieselmann V; Galla HJ; Matzner U
J Neurosci; 2014 Feb; 34(9):3122-9. PubMed ID: 24573272
[TBL] [Abstract][Full Text] [Related]
16. Tuning the Elasticity of Polymersomes for Brain Tumor Targeting.
Zheng M; Du Q; Wang X; Zhou Y; Li J; Xia X; Lu Y; Yin J; Zou Y; Park JB; Shi B
Adv Sci (Weinh); 2021 Oct; 8(20):e2102001. PubMed ID: 34423581
[TBL] [Abstract][Full Text] [Related]
17. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
[TBL] [Abstract][Full Text] [Related]
18. Folic Acid-Conjugated Brush Polymers Show Enhanced Blood-Brain Barrier Crossing in Static and Dynamic
Mazrad ZAI; Refaat A; Morrow JP; Voelcker NH; Nicolazzo JA; Leiske MN; Kempe K
ACS Biomater Sci Eng; 2024 May; 10(5):2894-2910. PubMed ID: 38556768
[TBL] [Abstract][Full Text] [Related]
19. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
20.
Gallego L; Ceña V
Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
